WeVote
Log In

Bill

Bill

SB 264

relative to the therapeutic cannabis program.

2025 Regular Session Introduced by Debra Altschiller and 6 co-sponsors

SB 264 sought to modify New Hampshire's therapeutic cannabis program but was rejected in Senate, failing to advance past procedural motions.

Inexpedient to Legislate, Senate Rule 3-23, 10/31/2025; SJ 1
0
WeVote Research Nonpartisan
Bill Summary · SB 264

Legislative bill overview

SB 264 proposed modifications to New Hampshire's therapeutic cannabis program, though specific amendments are not detailed in the legislative record provided. The bill was introduced by a bipartisan group of senators but ultimately failed to advance through the legislative process.

Why is this important

Therapeutic cannabis programs affect patient access to medical treatment, regulatory frameworks, and state healthcare policy. Changes to these programs can impact thousands of patients, healthcare providers, and the regulated cannabis industry in the state.

Potential points of contention

  • Program access and patient eligibility – Disagreement over which medical conditions qualify and how restrictive or permissive the program should be
  • Regulatory oversight and safety standards – Debates about government control, testing requirements, and dispensary operations
  • Implementation costs and funding – Questions about whether the program is adequately funded and who bears financial responsibility

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.